glutathione and triple negative breast cancer Role of in Cancer: From Mechanisms to Therapies GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Synthesis of micellar like terpolymer nanoparticles with reductively cleavable cross links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer ScienceDirect Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




